The pathogenic role of transforming growth factor-β2 in glaucomatous damage to the optic nerve head

Experimental Eye Research

Volumn 93, Issue 2, 2011, Pages 165-169

  Fuchshofer, Rudolf ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Astrocytes; Bone morphogenetic protein; Connective tissue growth factor; Extracellular matrix; Glaucoma; Gremlin; Optic nerve head; Transforming growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CONNECTIVE TISSUE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA2;

ASTROCYTE; AXOPLASM FLOW; CELL CULTURE; HUMAN; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASE; OPTIC NERVE FIBER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RETINA GANGLION CELL; REVIEW; VISUAL FIELD DEFECT;

ANIMALS; ASTROCYTES; BONE MORPHOGENETIC PROTEIN 4; CONNECTIVE TISSUE GROWTH FACTOR; EXTRACELLULAR MATRIX PROTEINS; GLAUCOMA, OPEN-ANGLE; HUMANS; OPTIC DISK; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS; TRANSFORMING GROWTH FACTOR BETA2;

EID: 80052807926     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2010.07.014     Document Type: Review

References (51)

1. Adams J.C., Kureishy N., Taylor A.L. A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1. J. Cell Biol. 2001, 152:1169-1182.
2. Attisano L., Wrana J.L. Signal transduction by the TGF-beta superfamily. Science 2002, 296:1646-1647.
3. Balemans W., Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev. Biol. 2002, 250:231-250.
4. Bornstein P. Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 2001, 107:929-934.
5. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors 2004, 22:233-241.
6. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am. J. Ophthalmol. 1998, 126:487-497. Collaborative-Normal-Tension-Glaucoma-Study-Group.
7. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am. J. Ophthalmol. 1998, 126:498-505. Collaborative-Normal-Tension-Glaucoma-Study-Group.
8. Crawford S.E., Stellmach V., Murphy-Ullrich J.E., Ribeiro S.M., Lawler J., Hynes R.O., Boivin G.P., Bouck N. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998, 93:1159-1170.
9. Fuchshofer R., Birke M., Welge-Lussen U., Kook D., Lutjen-Drecoll E. Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes. Invest. Ophthalmol. Vis. Sci. 2005, 46:568-578.
10. Fuchshofer R., Welge-Lussen U., Lutjen-Drecoll E. The effect of TGF-beta2 on human trabecular meshwork extracellular proteolytic system. Exp. Eye Res. 2003, 77:757-765.
11. Fuchshofer R., Yu A.H.L., Welge-Lussen U., Tamm E.R. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-{beta}2 in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 2007, 48:715-726.
12. Gordon M.O., Beiser J.A., Brandt J.D., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., Kass M.A. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol. 2002, 120:714-720. (discussion 829-730).
13. Gottanka J., Kuhlmann A., Scholz M., Johnson D.H., Lutjen-Drecoll E. Pathophysiologic changes in the optic nerves of eyes with primary open angle and pseudoexfoliation glaucoma. Invest. Ophthalmol. Vis. Sci. 2005, 46:4170-4181.
14. Granstein R.D., Staszewski R., Knisely T.L., Zeira E., Nazareno R., Latina M., Albert D.M. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J. Immunol. 1990, 144:3021-3027.
15. Grant W.M. Experimental aqueous perfusion in enucleated human eyes. Arch. Ophthalmol. 1963, 69:783-801.
16. Hernandez M.R., Andrzejewska W.M., Neufeld A.H. Changes in the extracellular matrix of the human optic nerve head in primary open-angle glaucoma. Am. J. Ophthalmol. 1990, 109:180-188.
17. Hernandez M.R., Igoe F., Neufeld A.H. Cell culture of the human lamina cribrosa. Invest. Ophthalmol. Vis. Sci. 1988, 29:78-89.
18. Hernandez M.R., Luo X.X., Andrzejewska W., Neufeld A.H. Age-related changes in the extracellular matrix of the human optic nerve head. Am. J. Ophthalmol. 1989, 107:476-484.
19. Hernandez M.R., Pena J.D., Selvidge J.A., Salvador-Silva M., Yang P. Hydrostatic pressure stimulates synthesis of elastin in cultured optic nerve head astrocytes. Glia 2000, 32:122-136.
20. Hernandez M.R., Ye H., Roy S. Collagen type IV gene expression in human optic nerve heads with primary open angle glaucoma. Exp. Eye Res. 1994, 59:41-51.
21. Inatani M., Tanihara H., Katsuta H., Honjo M., Kido N., Honda Y. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch. Clin. Exp. Ophthalmol. 2001, 239:109-113.
22. Johnson M. What controls aqueous humour outflow resistance?. Exp. Eye Res. 2006, 82:545-557.
23. Junglas B., Yu A.H., Welge-Lussen U., Tamm E.R., Fuchshofer R. Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells. Exp. Eye Res. 2009, 88:1065-1075.
24. Leske M.C., Heijl A., Hussein M., Bengtsson B., Hyman L., Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 2003, 121:48-56.
25. Lutjen-Drecoll E., Shimizu T., Rohrbach M., Rohen J.W. Quantitative analysis of 'plaque material' in the inner- and outer wall of Schlemm's canal in normal- and glaucomatous eyes. Exp. Eye Res. 1986, 42:443-455.
26. Murphy-Ullrich J.E., Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 2000, 11:59-69.
27. Neufeld A.H., Liu B. Glaucomatous optic neuropathy: when glia misbehave. Neuroscientist 2003, 9:485-495.
28. Neumann C., Yu A., Welge-Lussen U., Lutjen-Drecoll E., Birke M. The effect of TGF-beta2 on elastin, type VI collagen, and components of the proteolytic degradation system in human optic nerve astrocytes. Invest. Ophthalmol. Vis. Sci. 2008, 49:1464-1472.
29. Oyama T., Abe H., Ushiki T. The connective tissue and glial framework in the optic nerve head of the normal human eye: light and scanning electron microscopic studies. Arch. Histol. Cytol. 2006, 69:341-356.
30. Pena J.D., Netland P.A., Vidal I., Dorr D.A., Rasky A., Hernandez M.R. Elastosis of the lamina cribrosa in glaucomatous optic neuropathy. Exp. Eye Res. 1998, 67:517-524.
31. Pena J.D., Roy S., Hernandez M.R. Tropoelastin gene expression in optic nerve heads of normal and glaucomatous subjects. Matrix Biol. 1996, 15:323-330.
32. Pena J.D., Taylor A.W., Ricard C.S., Vidal I., Hernandez M.R. Transforming growth factor beta isoforms in human optic nerve heads. Br. J. Ophthalmol. 1999, 83:209-218.
33. Pena J.D., Varela H.J., Ricard C.S., Hernandez M.R. Enhanced tenascin expression associated with reactive astrocytes in human optic nerve heads with primary open angle glaucoma. Exp. Eye Res. 1999, 68:29-40.
34. Pfeffer B.A., Flanders K.C., Guerin C.J., Danielpour D., Anderson D.H. Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp. Eye Res. 1994, 59:323-333.
35. Picht G., Welge-Luessen U., Grehn F., Lutjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch. Clin. Exp. Ophthalmol. 2001, 239:199-207.
36. Quigley H.A. Open-angle glaucoma. N. Engl. J. Med. 1993, 328:1097-1106.
37. Quigley H.A., Addicks E.M. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest. Ophthalmol. Vis. Sci. 1980, 19:137-152.
38. Quigley H.A., Hohman R.M., Addicks E.M., Massof R.W., Green W.R. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am. J. Ophthalmol. 1983, 95:673-691.
39. Quigley H.A., McKinnon S.J., Zack D.J., Pease M.E., Kerrigan-Baumrind L.A., Kerrigan D.F., Mitchell R.S. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest. Ophthalmol. Vis. Sci. 2000, 41:3460-3466.
40. Rohen J.W., Lutjen-Drecoll E., Flugel C., Meyer M., Grierson I. Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp. Eye Res. 1993, 56:683-692.
41. Schultz-Cherry S., Ribeiro S., Gentry L., Murphy-Ullrich J.E. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J. Biol. Chem. 1994, 269:26775-26782.
42. Tamm E.R., Fuchshofer R. What increases outflow resistance in primary open-angle glaucoma. Surv. Ophthalmol. 2007, 52(Suppl. 2):S101-S104.
43. The-AGIS-Investigators The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 2000, 130:429-440.
44. Tomarev S.I., Wistow G., Raymond V., Dubois S., Malyukova I. Gene expression profile of the human trabecular meshwork: NEIBank sequence tag analysis. Invest. Ophthalmol. Vis. Sci. 2003, 44:2588-2596.
45. Tripathi R.C., Li J., Chan W.F., Tripathi B.J. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp. Eye Res. 1994, 59:723-727.
46. van Setten G.B., Blalock T.D., Grotendorst G., Schultz G.S. Detection of connective tissue growth factor in human aqueous humor. Ophthal. Res. 2002, 34:306.
47. Varela H.J., Hernandez M.R. Astrocyte responses in human optic nerve head with primary open-angle glaucoma. J. Glaucoma 1997, 6:303-313.
48. Wordinger R.J., Agarwal R., Talati M., Fuller J., Lambert W., Clark A.F. Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol. Vis. 2002, 8:241-250.
49. Yang P., Hernandez M.R. Purification of astrocytes from adult human optic nerve heads by immunopanning. Brain Res. Brain Res. Protoc. 2003, 12:67-76.
50. Zode G.S., Clark A.F., Wordinger R.J. Activation of the BMP canonical signaling pathway in human optic nerve head tissue and isolated optic nerve head astrocytes and lamina cribrosa cells. Invest Ophthalmol. Vis. Sci. 2007, 48:5058-5067.
51. Zode G.S., Clark A.F., Wordinger R.J. Bone morphogenetic protein 4 inhibits TGF-beta2 stimulation of extracellular matrix proteins in optic nerve head cells: role of gremlin in ECM modulation. Glia 2009, 57:755-766.